`
`(PATENT)
`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`In re Patent Application of:
`Masayuki SAIKI et al.
`
`: Customer Number: 20277
`'
`
`Application No.: 15/323,001
`
`: Confirmation No.2 3657
`
`Filed: December 29, 2016
`
`2 Art Unit: 1798
`
`For: SUBSTRATE FOR SAMPLE ANALYSIS, AND: Examiner: J. Nagpaul
`SAMPLE ANALYSIS APPARATUS
`
`INFORMATION DISCLOSURE STATEMENT ngSl
`
`MS Amendment
`
`Commissioner for Patents
`
`PO. Box 1450
`
`Alexandria, VA 22313-1450
`
`Madam:
`
`Pursuant to 37 C.F.R. §§ 1.56, 1.97, and 1.98, the attention of the United States Patent and
`
`Trademark Office is hereby directed to the references listed on the attached PTO/SB/08.
`
`It is
`
`respectfully requested that the information be expressly considered during the prosecution of the
`
`above-identified application, and that the references be made of record therein and appear among
`
`the “References Cited” on any patent to issue therefrom.
`
`In accordance with 37 C.F.R. § 1.98(a)(2)(ii), copies of US. patents and US. patent
`
`application publications are not submitted. Submitted herewith are copies of the non-patent
`
`literature in accordance with 37 C.F.R. § 1.98(a)(2).
`
`This Information Disclosure Statement is filed after the mailing date of a first Office Action
`
`on the merits, but before the mailing date of any of a Final Action under 37 C.F.R. § 1.113, a Notice
`
`of Allowance under 37 C.F.R. § 1.311 or an action that otherwise closes prosecution in this
`
`application (37 C.F.R. § 1.97(c)). The required certifications are submitted below.
`
`Some of the references listed on the attached Form PTO/SB/08 were first cited in any
`
`communication from a foreign patent office in a counterpart foreign application not more than three
`
`months prior to the filing of the information disclosure statement. See C.F.R. § 1.97(e)(1).
`
`Specifically:
`
`
`
`Application No. 15/323,001
`
`Docket No.: 096534-0014
`
`1. US 2008/0171400; and
`
`2. US 2013/0206701.
`
`As to the remaining items of information, pursuant to 37 CPR. § 197(c)(2), such remaining
`
`items were not cited in a communication from a foreign patent office in a counterpart foreign
`
`application and to the knowledge of the person signing the certification after making reasonable
`
`inquiry, were not known to any individual designated in 37 CPR. § l.56(c) more than three months
`
`prior to the filing of this Information Disclosure Statement.
`
`In accordance with 37 CPR. § 1.97(g), the filing of this Information Disclosure Statement
`
`shall not be construed as a representation that a search has been made. In accordance with
`
`37 C.F.R. § 1.97(h), the filing of this Information Disclosure Statement shall not be construed to be
`
`an admission that the information cited in this Information Disclosure Statement is, or is considered
`
`to be, material to the patentability as defined in 37 C.F.R. § 1.56(b).
`
`It is submitted that the Information Disclosure Statement is in compliance with
`
`37 C.F.R. § 1.98, and the Examiner is respectfully requested to consider the listed references.
`
`Applicant believes no fee is due with this response. However, if a fee is due, please charge
`
`our Deposit Account No. 50-0417, under Order No. 096534—0014 from which the undersigned is
`
`authorized to draw.
`
`Respectfully submitted,
`
`MCDERMOTT WILL & EMERY LLP
`
`/Bernard P. Codd/ [WC
`
`Bernard P. Codd
`
`Registration No. 46,429
`
`Please recognize our Customer No. 20277 as
`our correspondence address.
`
`The McDermott Building
`500 North Capitol Street, NW
`Washington, DC 20001-1531
`Phone: (202) 756—8182 BPCznso
`Facsimile:
`(202) 756-8087
`Date: June 28, 2019
`
`